We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.27%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$8.87B
AUM Growth
+$1.06B
(+14%)
Cap. Flow
+$639M
Cap. Flow
% of AUM
7.2%
Top 10 Holdings %
Top 10 Hldgs %
4.17%
Holding
3,246
New
442
Increased
1,245
Reduced
1,198
Closed
351
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Okta
OKTA
|
+$37.2M |
| 2 |
Linde
LIN
|
+$31.4M |
| 3 |
Take-Two Interactive
TTWO
|
+$30M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$27.4M |
| 5 |
Walmart Inc
WMT
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$46.1M |
| 2 |
PayPal
PYPL
|
+$31.4M |
| 3 |
Apple
AAPL
|
+$31.3M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$28M |
| 5 |
Merck
MRK
|
+$27.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Consumer Discretionary | 15.85% |
| 3 | Healthcare | 13.89% |
| 4 | Industrials | 12.4% |
| 5 | Financials | 11.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
vTv Therapeutics
VTVT
$139M
| $32K | ﹤0.01% |
+354
| New | +$35.9K |
|
2827
International Flavors & Fragrances
IFF
$21.9B
| $31K | ﹤0.01% |
210
-6,907
| -97% | -$991K |
|
2828
Navigator Holdings
NVGS
$1.28B
| $30K | ﹤0.01% |
+2,737
| New | +$28.9K |
|
|
GRA
2829
DELISTED
W.R. Grace & Co.
GRA
| $30K | ﹤0.01% |
438
-53,691
| -99% | -$3.62M |
|
2830
Sprinklr
CXM
$1.61B
| $29K | ﹤0.01% |
+1,400
| New | +$29.3K |
|
2831
Denison Mines
DNN
$2.91B
| $29K | ﹤0.01% |
+23,700
| New | +$28.4K |
|
2832
Fulcrum Therapeutics
FULC
$297M
| $29K | ﹤0.01% |
2,795
-860
| -24% | -$8.69K |
|
2833
Mirum Pharmaceuticals
MIRM
$6.14B
| $28K | ﹤0.01% |
1,618
-6,641
| -80% | -$119K |
|
2834
Nautilus Biotechnolgy
NAUT
$115M
| $28K | ﹤0.01% |
+2,750
| New | +$29.8K |
|
|
KDNY
2835
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $28K | ﹤0.01% |
+1,991
| New | +$31.8K |
|
2836
Iovance Biotherapeutics
IOVA
$2.87B
| $27K | ﹤0.01% |
1,042
-97,600
| -99% | -$2.54M |
|
2837
Bakkt Inc
BKKT
$337M
| $26K | ﹤0.01% |
103
-361
| -78% | -$99.3K |
|
2838
iBio
IBIO
$70M
| $25K | ﹤0.01% |
33
-45
| -58% | -$32.8K |
|
2839
Insmed
INSM
$28.6B
| $23K | ﹤0.01% |
817
-10,161
| -93% | -$302K |
|
2840
PubMatic
PUBM
$810M
| $23K | ﹤0.01% |
+600
| New | +$25K |
|
2841
Transmedics
TMDX
$2.91B
| $22K | ﹤0.01% |
677
-2,670
| -80% | -$74K |
|
2842
Zentalis Pharmaceuticals
ZNTL
$302M
| $22K | ﹤0.01% |
+417
| New | +$22.3K |
|
|
SREV
2843
DELISTED
ServiceSource International, Inc.
SREV
| $22K | ﹤0.01% |
15,419
+4,291
| +39% | +$5.64K |
|
2844
The Ensign Group
ENSG
$10.7B
| $21K | ﹤0.01% |
+243
| New | +$21K |
|
|
VERV
2845
DELISTED
Verve Therapeutics
VERV
| $21K | ﹤0.01% |
+351
| New | +$14.6K |
|
|
NEUE
2846
DELISTED
NeueHealth
NEUE
| $21K | ﹤0.01% |
+15
| New | +$20.6K |
|
2847
Installed Building Products
IBP
$6.49B
| $20K | ﹤0.01% |
160
-12,194
| -99% | -$1.49M |
|
2848
Lifestance Health
LFST
$4.14B
| $20K | ﹤0.01% |
+700
| New | +$18.5K |
|
|
MRUS
2849
DELISTED
Merus
MRUS
| $20K | ﹤0.01% |
+951
| New | +$21K |
|
2850
Dyne Therapeutics
DYN
$4.9B
| $19K | ﹤0.01% |
+912
| New | +$17.1K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q2 2021 Portfolio in Review
As of Q2 2021, Cubist Systematic Strategies held 3,246 positions worth $8.87B, up 14% from $7.81B the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.
Cubist Systematic Strategies deployed $639M of net new capital in Q2 2021, opening 442 new positions and adding to 1,245 existing holdings. Its largest new stake was American Tower: 39,022 shares worth $10.5M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Aptiv, an estimated $46.1M trimmed.
- Cubist Systematic Strategies's largest Q2 2021 buy was American Tower: 39,022 shares worth $10.5M.
- Cubist Systematic Strategies added most to Okta in Q2 2021, an estimated $37.2M increase.
- Cubist Systematic Strategies's biggest Q2 2021 reduction was Aptiv, cutting an estimated $46.1M.
- Cubist Systematic Strategies fully exited Toro Company in Q2 2021, selling an estimated $7.31M.
- Cubist Systematic Strategies's ten largest holdings make up 4.2% of its $8.87B portfolio in Q2 2021.
- Cubist Systematic Strategies opened 442 new positions and closed 351 in Q2 2021.
- Cubist Systematic Strategies's portfolio value rose 14% quarter-over-quarter to $8.87B.
Based on Cubist Systematic Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.